Global Retinal Drugs and Biologics Market Outlook 2021

Table of Contents

1 Retinal Drugs and Biologics Market Overview
1.1 Product Overview and Scope of Retinal Drugs and Biologics
1.2 Retinal Drugs and Biologics Segment by Type
1.2.1 Global Retinal Drugs and Biologics Sales Growth Rate Comparison by Type (2020-2026)
1.2.2 Age Related Macular Degeneration
1.2.3 Diabetic Retinopathy
1.2.4 Ocular Inflammatory Disease (Uveitis)
1.2.5 Macular Hole
1.3 Retinal Drugs and Biologics Segment by Application
1.3.1 Retinal Drugs and Biologics Sales Comparison by Application: (2020-2026)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Retinal Drugs and Biologics Market Size Estimates and Forecasts
1.4.1 Global Retinal Drugs and Biologics Revenue 2015-2026
1.4.2 Global Retinal Drugs and Biologics Sales 2015-2026
1.4.3 Retinal Drugs and Biologics Market Size by Region: 2020 Versus 2026

2 Global Retinal Drugs and Biologics Market Competition by Manufacturers
2.1 Global Retinal Drugs and Biologics Sales Market Share by Manufacturers (2015-2020)
2.2 Global Retinal Drugs and Biologics Revenue Share by Manufacturers (2015-2020)
2.3 Global Retinal Drugs and Biologics Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Retinal Drugs and Biologics Manufacturing Sites, Area Served, Product Type
2.5 Retinal Drugs and Biologics Market Competitive Situation and Trends
2.5.1 Retinal Drugs and Biologics Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Retinal Drugs and Biologics Players (Opinion Leaders)

3 Retinal Drugs and Biologics Retrospective Market Scenario by Region
3.1 Global Retinal Drugs and Biologics Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Retinal Drugs and Biologics Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Retinal Drugs and Biologics Market Facts & Figures by Country
3.3.1 North America Retinal Drugs and Biologics Sales by Country
3.3.2 North America Retinal Drugs and Biologics Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Retinal Drugs and Biologics Market Facts & Figures by Country
3.4.1 Europe Retinal Drugs and Biologics Sales by Country
3.4.2 Europe Retinal Drugs and Biologics Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Retinal Drugs and Biologics Market Facts & Figures by Region
3.5.1 Asia Pacific Retinal Drugs and Biologics Sales by Region
3.5.2 Asia Pacific Retinal Drugs and Biologics Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Retinal Drugs and Biologics Market Facts & Figures by Country
3.6.1 Latin America Retinal Drugs and Biologics Sales by Country
3.6.2 Latin America Retinal Drugs and Biologics Sales by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Retinal Drugs and Biologics Market Facts & Figures by Country
3.7.1 Middle East and Africa Retinal Drugs and Biologics Sales by Country
3.7.2 Middle East and Africa Retinal Drugs and Biologics Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Retinal Drugs and Biologics Historic Market Analysis by Type
4.1 Global Retinal Drugs and Biologics Sales Market Share by Type (2015-2020)
4.2 Global Retinal Drugs and Biologics Revenue Market Share by Type (2015-2020)
4.3 Global Retinal Drugs and Biologics Price Market Share by Type (2015-2020)
4.4 Global Retinal Drugs and Biologics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Retinal Drugs and Biologics Historic Market Analysis by Application
5.1 Global Retinal Drugs and Biologics Sales Market Share by Application (2015-2020)
5.2 Global Retinal Drugs and Biologics Revenue Market Share by Application (2015-2020)
5.3 Global Retinal Drugs and Biologics Price by Application (2015-2020)

6 Company Profiles and Key Figures in Retinal Drugs and Biologics Business
6.1 ALLERGAN
6.1.1 Corporation Information
6.1.2 ALLERGAN Description, Business Overview
6.1.3 ALLERGAN Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2015-2020)
6.1.4 ALLERGAN Products Offered
6.1.5 ALLERGAN Recent Development
6.2 AbbVie
6.2.1 AbbVie Corporation Information
6.2.2 AbbVie Description, Business Overview
6.2.3 AbbVie Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2015-2020)
6.2.4 AbbVie Products Offered
6.2.5 AbbVie Recent Development
6.3 Alimera Sciences
6.3.1 Alimera Sciences Corporation Information
6.3.2 Alimera Sciences Description, Business Overview
6.3.3 Alimera Sciences Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Alimera Sciences Products Offered
6.3.5 Alimera Sciences Recent Development
6.4 Janssen Biotech
6.4.1 Janssen Biotech Corporation Information
6.4.2 Janssen Biotech Description, Business Overview
6.4.3 Janssen Biotech Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Janssen Biotech Products Offered
6.4.5 Janssen Biotech Recent Development
6.5 Swedish Orphan Biovitrum
6.5.1 Swedish Orphan Biovitrum Corporation Information
6.5.2 Swedish Orphan Biovitrum Description, Business Overview
6.5.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Swedish Orphan Biovitrum Products Offered
6.5.5 Swedish Orphan Biovitrum Recent Development
6.6 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description, Business Overview
6.6.3 Roche Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Roche Products Offered
6.6.5 Roche Recent Development
6.7 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description, Business Overview
6.6.3 Bristol-Myers Squibb Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Bristol-Myers Squibb Products Offered
6.7.5 Bristol-Myers Squibb Recent Development
6.8 Genzyme
6.8.1 Genzyme Corporation Information
6.8.2 Genzyme Description, Business Overview
6.8.3 Genzyme Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Genzyme Products Offered
6.8.5 Genzyme Recent Development
6.9 Genentech
6.9.1 Genentech Corporation Information
6.9.2 Genentech Description, Business Overview
6.9.3 Genentech Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Genentech Products Offered
6.9.5 Genentech Recent Development
6.10 OCULAR THERAPEUTIX
6.10.1 OCULAR THERAPEUTIX Corporation Information
6.10.2 OCULAR THERAPEUTIX Description, Business Overview
6.10.3 OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2015-2020)
6.10.4 OCULAR THERAPEUTIX Products Offered
6.10.5 OCULAR THERAPEUTIX Recent Development
6.11 Bausch & Lomb
6.11.1 Bausch & Lomb Corporation Information
6.11.2 Bausch & Lomb Retinal Drugs and Biologics Description, Business Overview
6.11.3 Bausch & Lomb Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Bausch & Lomb Products Offered
6.11.5 Bausch & Lomb Recent Development
6.12 UCBCares
6.12.1 UCBCares Corporation Information
6.12.2 UCBCares Retinal Drugs and Biologics Description, Business Overview
6.12.3 UCBCares Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2015-2020)
6.12.4 UCBCares Products Offered
6.12.5 UCBCares Recent Development

7 Retinal Drugs and Biologics Manufacturing Cost Analysis
7.1 Retinal Drugs and Biologics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Retinal Drugs and Biologics
7.4 Retinal Drugs and Biologics Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Retinal Drugs and Biologics Distributors List
8.3 Retinal Drugs and Biologics Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global Retinal Drugs and Biologics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Retinal Drugs and Biologics by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Retinal Drugs and Biologics by Type (2021-2026)
10.2 Retinal Drugs and Biologics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Retinal Drugs and Biologics by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Retinal Drugs and Biologics by Application (2021-2026)
10.3 Retinal Drugs and Biologics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Retinal Drugs and Biologics by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Retinal Drugs and Biologics by Region (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables
Table 1. Global Retinal Drugs and Biologics Sales (K MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Retinal Drugs and Biologics Sales (K MT) Comparison by Application: 2020 VS 2026
Table 3. Global Retinal Drugs and Biologics Market Size by Type (K MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Retinal Drugs and Biologics Manufacturers Covered in This Study
Table 5. Global Retinal Drugs and Biologics Sales (K MT) by Manufacturers (2015-2020)
Table 6. Global Retinal Drugs and Biologics Sales Share by Manufacturers (2015-2020)
Table 7. Global Retinal Drugs and Biologics Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Retinal Drugs and Biologics Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Retinal Drugs and Biologics Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Retinal Drugs and Biologics Sales Sites and Area Served
Table 11. Manufacturers Retinal Drugs and Biologics Product Types
Table 12. Global Retinal Drugs and Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Retinal Drugs and Biologics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Drugs and Biologics as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Retinal Drugs and Biologics Players
Table 16. Global Retinal Drugs and Biologics Sales (K MT) by Region (2015-2020)
Table 17. Global Retinal Drugs and Biologics Sales Market Share by Region (2015-2020)
Table 18. Global Retinal Drugs and Biologics Revenue (Million US$) by Region (2015-2020)
Table 19. Global Retinal Drugs and Biologics Revenue Market Share by Region (2015-2020)
Table 20. North America Retinal Drugs and Biologics Sales by Country (2015-2020) (K MT)
Table 21. North America Retinal Drugs and Biologics Sales Market Share by Country (2015-2020)
Table 22. North America Retinal Drugs and Biologics Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Retinal Drugs and Biologics Revenue Market Share by Country (2015-2020)
Table 24. Europe Retinal Drugs and Biologics Sales by Country (2015-2020) (K MT)
Table 25. Europe Retinal Drugs and Biologics Sales Market Share by Country (2015-2020)
Table 26. Europe Retinal Drugs and Biologics Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Retinal Drugs and Biologics Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Retinal Drugs and Biologics Sales by Region (2015-2020) (K MT)
Table 29. Asia Pacific Retinal Drugs and Biologics Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Retinal Drugs and Biologics Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Retinal Drugs and Biologics Revenue Market Share by Region (2015-2020)
Table 32. Latin America Retinal Drugs and Biologics Sales by Country (2015-2020) (K MT)
Table 33. Latin America Retinal Drugs and Biologics Sales Market Share by Country (2015-2020)
Table 34. Latin America Retinal Drugs and Biologics Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Retinal Drugs and Biologics Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Retinal Drugs and Biologics Sales by Country (2015-2020) (K MT)
Table 37. Middle East and Africa Retinal Drugs and Biologics Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Retinal Drugs and Biologics Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Retinal Drugs and Biologics Revenue Market Share by Country (2015-2020)
Table 40. Global Retinal Drugs and Biologics Sales (K MT) by Type (2015-2020)
Table 41. Global Retinal Drugs and Biologics Sales Share by Type (2015-2020)
Table 42. Global Retinal Drugs and Biologics Revenue (Million US$) by Type (2015-2020)
Table 43. Global Retinal Drugs and Biologics Revenue Share by Type (2015-2020)
Table 44. Global Retinal Drugs and Biologics Price (USD/MT) by Type (2015-2020)
Table 45. Global Retinal Drugs and Biologics Sales (K MT) by Application (2015-2020)
Table 46. Global Retinal Drugs and Biologics Sales Market Share by Application (2015-2020)
Table 47. Global Retinal Drugs and Biologics Sales Growth Rate by Application (2015-2020)
Table 48. ALLERGAN Corporation Information
Table 49. ALLERGAN Description and Business Overview
Table 50. ALLERGAN Retinal Drugs and Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. ALLERGAN Main Product
Table 52. ALLERGAN Recent Development
Table 53. AbbVie Corporation Information
Table 54. AbbVie Description and Business Overview
Table 55. AbbVie Retinal Drugs and Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. AbbVie Main Product
Table 57. AbbVie Recent Development
Table 58. Alimera Sciences Corporation Information
Table 59. Alimera Sciences Description and Business Overview
Table 60. Alimera Sciences Retinal Drugs and Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Alimera Sciences Main Product
Table 62. Alimera Sciences Recent Development
Table 63. Janssen Biotech Corporation Information
Table 64. Janssen Biotech Description and Business Overview
Table 65. Janssen Biotech Retinal Drugs and Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. Janssen Biotech Main Product
Table 67. Janssen Biotech Recent Development
Table 68. Swedish Orphan Biovitrum Corporation Information
Table 69. Swedish Orphan Biovitrum Description and Business Overview
Table 70. Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. Swedish Orphan Biovitrum Main Product
Table 72. Swedish Orphan Biovitrum Recent Development
Table 73. Roche Corporation Information
Table 74. Roche Description and Business Overview
Table 75. Roche Retinal Drugs and Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Roche Main Product
Table 77. Roche Recent Development
Table 78. Bristol-Myers Squibb Corporation Information
Table 79. Bristol-Myers Squibb Description and Business Overview
Table 80. Bristol-Myers Squibb Retinal Drugs and Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Bristol-Myers Squibb Main Product
Table 82. Bristol-Myers Squibb Recent Development
Table 83. Genzyme Corporation Information
Table 84. Genzyme Description and Business Overview
Table 85. Genzyme Retinal Drugs and Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. Genzyme Main Product
Table 87. Genzyme Recent Development
Table 88. Genentech Corporation Information
Table 89. Genentech Description and Business Overview
Table 90. Genentech Retinal Drugs and Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Genentech Main Product
Table 92. Genentech Recent Development
Table 93. OCULAR THERAPEUTIX Corporation Information
Table 94. OCULAR THERAPEUTIX Description and Business Overview
Table 95. OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. OCULAR THERAPEUTIX Main Product
Table 97. OCULAR THERAPEUTIX Recent Development
Table 98. Bausch & Lomb Corporation Information
Table 99. Bausch & Lomb Description and Business Overview
Table 100. Bausch & Lomb Retinal Drugs and Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 101. Bausch & Lomb Main Product
Table 102. Bausch & Lomb Recent Development
Table 103. UCBCares Corporation Information
Table 104. UCBCares Description and Business Overview
Table 105. UCBCares Retinal Drugs and Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 106. UCBCares Main Product
Table 107. UCBCares Recent Development
Table 108. Production Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Retinal Drugs and Biologics Distributors List
Table 111. Retinal Drugs and Biologics Customers List
Table 112. Retinal Drugs and Biologics Market Trends
Table 113. Retinal Drugs and Biologics Opportunities and Drivers
Table 114. Retinal Drugs and Biologics Market Challenges
Table 115. Global Retinal Drugs and Biologics Sales (K MT) Forecast by Type (2021-2026)
Table 116. Global Retinal Drugs and Biologics Sales Market Share Forecast by Type (2021-2026)
Table 117. Global Retinal Drugs and Biologics Revenue (Million US$) Forecast by Type (2021-2026)
Table 118. Global Retinal Drugs and Biologics Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 119. Global Retinal Drugs and Biologics Sales (K MT) Forecast by Application (2021-2026)
Table 120. Global Retinal Drugs and Biologics Revenue (Million US$) Forecast by Application (2021-2026)
Table 121. Global Retinal Drugs and Biologics Sales (K MT) Forecast by Region (2021-2026)
Table 122. Global Retinal Drugs and Biologics Sales Market Share Forecast by Region (2021-2026)
Table 123. Global Retinal Drugs and Biologics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Global Retinal Drugs and Biologics Revenue Market Share Forecast by Region (2021-2026)
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Retinal Drugs and Biologics
Figure 2. Global Retinal Drugs and Biologics Sales Market Share by Type: 2020 VS 2026
Figure 3. Age Related Macular Degeneration Product Picture
Figure 4. Diabetic Retinopathy Product Picture
Figure 5. Ocular Inflammatory Disease (Uveitis) Product Picture
Figure 6. Macular Hole Product Picture
Figure 7. Global Retinal Drugs and Biologics Consumption Market Share by Application: 2020 VS 2026
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global Retinal Drugs and Biologics Market Size 2015-2026 (US$ Million)
Figure 12. Global Retinal Drugs and Biologics Sales Capacity (K MT) (2015-2026)
Figure 13. Global Retinal Drugs and Biologics Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Retinal Drugs and Biologics Sales Share by Manufacturers in 2020
Figure 15. Global Retinal Drugs and Biologics Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Retinal Drugs and Biologics Revenue in 2019
Figure 17. Retinal Drugs and Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Retinal Drugs and Biologics Sales Market Share by Region (2015-2020)
Figure 19. Global Retinal Drugs and Biologics Sales Market Share by Region in 2019
Figure 20. Global Retinal Drugs and Biologics Revenue Market Share by Region (2015-2020)
Figure 21. Global Retinal Drugs and Biologics Revenue Market Share by Region in 2019
Figure 22. North America Retinal Drugs and Biologics Sales Market Share by Country in 2019
Figure 23. North America Retinal Drugs and Biologics Revenue Market Share by Country in 2019
Figure 24. U.S. Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 25. U.S. Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 27. Canada Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Retinal Drugs and Biologics Sales Market Share by Country in 2019
Figure 29. Europe Retinal Drugs and Biologics Revenue Market Share by Country in 2019
Figure 30. Germany Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 31. Germany Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 33. France Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.K. Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 37. Italy Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 39. Russia Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Retinal Drugs and Biologics Sales Market Share by Region in 2019
Figure 41. Asia Pacific Retinal Drugs and Biologics Revenue Market Share by Region in 2019
Figure 42. China Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 43. China Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 45. Japan Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 47. South Korea Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 49. India Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 51. Australia Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 53. Taiwan Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 55. Indonesia Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 57. Thailand Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 59. Malaysia Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 61. Philippines Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 63. Vietnam Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Retinal Drugs and Biologics Sales Market Share by Country in 2019
Figure 65. Latin America Retinal Drugs and Biologics Revenue Market Share by Country in 2019
Figure 66. Mexico Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 67. Mexico Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 69. Brazil Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 71. Argentina Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Retinal Drugs and Biologics Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Retinal Drugs and Biologics Revenue Market Share by Country in 2019
Figure 74. Turkey Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 75. Turkey Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 77. Saudi Arabia Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. U.A.E Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 79. U.A.E Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Retinal Drugs and Biologics by Type (2015-2020)
Figure 81. Sales Market Share of Retinal Drugs and Biologics by Type in 2020
Figure 82. Global Retinal Drugs and Biologics Market Share by Price Range (2015-2020)
Figure 83. Revenue Market Share of Retinal Drugs and Biologics by Type in 2019
Figure 84. Global Retinal Drugs and Biologics Sales Growth by Type (2015-2020) (K MT)
Figure 85. Sales Market Share of Retinal Drugs and Biologics by Application (2015-2020)
Figure 86. Sales Market Share of Retinal Drugs and Biologics by Application in 2020
Figure 87. Revenue Share of Retinal Drugs and Biologics by Application (2015-2020)
Figure 88. Revenue Share of Retinal Drugs and Biologics by Application in 2020
Figure 89. Key Raw Materials Price Trend
Figure 90. Manufacturing Cost Structure of Retinal Drugs and Biologics
Figure 91. Manufacturing Process Analysis of Retinal Drugs and Biologics
Figure 92. Retinal Drugs and Biologics Industrial Chain Analysis
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Porter's Five Forces Analysis
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed